-
1
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
-
(2007)
Ann Oncol
, vol.18
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
-
2
-
-
21044443320
-
ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer
-
Tveit K. ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol 2005; 16 (Suppl 1): I20-i21.
-
(2005)
Ann Oncol
, vol.16
, Issue.SUPPL. 1
-
-
Tveit, K.1
-
3
-
-
48749107348
-
-
European Network of Cancer Registries. EUROCIM Version 4.0. European Incidence Database V2.2. (1999). Lyon, France: International Agency for Research on Cancer 2001.
-
European Network of Cancer Registries. EUROCIM Version 4.0. European Incidence Database V2.2. (1999). Lyon, France: International Agency for Research on Cancer 2001.
-
-
-
-
5
-
-
6044226542
-
Preoperative versus postoperative chemoradiotherapy for rectal cancer
-
Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
-
(2004)
N Engl J Med
, vol.351
, pp. 1731-1740
-
-
Sauer, R.1
Becker, H.2
Hohenberger, W.3
-
6
-
-
33748676449
-
Chemotherapy with preoperative radiotherapy in rectal cancer
-
Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
-
(2006)
N Engl J Med
, vol.355
, pp. 1114-1123
-
-
Bosset, J.F.1
Collette, L.2
Calais, G.3
-
7
-
-
48749107599
-
-
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Rectal Cancer. V1,2008. http://www.nccn.org/professionals/ physician_gls/PDF/rectal.pdf (12 February 2008, date last accessed).
-
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Rectal Cancer. V1,2008. http://www.nccn.org/professionals/ physician_gls/PDF/rectal.pdf (12 February 2008, date last accessed).
-
-
-
-
8
-
-
33747067709
-
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144
-
Smalley SR, Benedetti JK, Williamson SK et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006; 24: 3542-3547.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3542-3547
-
-
Smalley, S.R.1
Benedetti, J.K.2
Williamson, S.K.3
-
9
-
-
0031022803
-
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
-
Webb A, Cunningham D, Scarffe JH et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997; 15: 261-267.
-
(1997)
J Clin Oncol
, vol.15
, pp. 261-267
-
-
Webb, A.1
Cunningham, D.2
Scarffe, J.H.3
-
10
-
-
0037090686
-
Prospective randomized trial comparing mitomycin, cisolatin and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin and PVI 5-FU in advanced esophagogastric cancer
-
Ross P, Nicolson M, Cunningham D et al. Prospective randomized trial comparing mitomycin, cisolatin and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20: 1996-2004.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1996-2004
-
-
Ross, P.1
Nicolson, M.2
Cunningham, D.3
-
11
-
-
0031691506
-
Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1- (2′-tetrahydrofuryl -5-fluorouracil
-
Ho DH, Pazdur R, Covington W et al. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1- (2′-tetrahydrofuryl -5-fluorouracil. Clin Cancer Res 1998; 4: 2085-2088.
-
(1998)
Clin Cancer Res
, vol.4
, pp. 2085-2088
-
-
Ho, D.H.1
Pazdur, R.2
Covington, W.3
-
12
-
-
0036731818
-
Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patents with previously untreated metastatic colorectal cancer
-
Douillard JY, Hoff PM, Skillings JR et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patents with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20: 3605-3616.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3605-3616
-
-
Douillard, J.Y.1
Hoff, P.M.2
Skillings, J.R.3
-
13
-
-
0036727089
-
Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
-
Carmichael J, Popiela T, Radstone D et al. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20: 3617-3627.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3617-3627
-
-
Carmichael, J.1
Popiela, T.2
Radstone, D.3
-
14
-
-
0037231279
-
Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma
-
Taguchi T, Ikeda Y, Mikami Y et al. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. Anticancer Res 2003; 23(1B): 713-717.
-
(2003)
Anticancer Res
, vol.23
, Issue.1 B
, pp. 713-717
-
-
Taguchi, T.1
Ikeda, Y.2
Mikami, Y.3
-
15
-
-
6544295384
-
UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
-
Ichinose Y, Yano T, Asoh H et al. UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer. Oncology (Huntingt) 1999; 13 (7 Suppl 3): 98-101.
-
(1999)
Oncology (Huntingt)
, vol.13
, Issue.7 SUPPL. 3
, pp. 98-101
-
-
Ichinose, Y.1
Yano, T.2
Asoh, H.3
-
16
-
-
1542603282
-
Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer
-
Byström P, Frödin JE, Berglund Å et al. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer. Radiother OnGol 2004; 70: 171-175.
-
(2004)
Radiother OnGol
, vol.70
, pp. 171-175
-
-
Byström, P.1
Frödin, J.E.2
Berglund, A.3
-
17
-
-
0036235128
-
First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
-
Cassidy J, Twelves C, Van Cutsem E et al. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002; 13: 566-575.
-
(2002)
Ann Oncol
, vol.13
, pp. 566-575
-
-
Cassidy, J.1
Twelves, C.2
Van Cutsem, E.3
-
18
-
-
7344243730
-
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study
-
Aranda E, Diaz-Rubio E, Cervantes A et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study. Ann Oncol 1998; 9: 727-731.
-
(1998)
Ann Oncol
, vol.9
, pp. 727-731
-
-
Aranda, E.1
Diaz-Rubio, E.2
Cervantes, A.3
-
19
-
-
0031017851
-
Patient preferences for oral versus intravenous palliative chemotherapy
-
Liu B, Franssen E, Fitch MI, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 1997; 15: 110-115.
-
(1997)
J Clin Oncol
, vol.15
, pp. 110-115
-
-
Liu, B.1
Franssen, E.2
Fitch, M.I.3
Warner, E.4
-
20
-
-
0036159485
-
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectall cancer
-
Borner MM, Schoffski P, de Wit R et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectall cancer. Eur J Cancer 2002; 38: 349-358.
-
(2002)
Eur J Cancer
, vol.38
, pp. 349-358
-
-
Borner, M.M.1
Schoffski, P.2
de Wit, R.3
-
21
-
-
33750179595
-
Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer
-
Pfeiffer P, Mortensen JP, Bjerregaard B et al. Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer. Eur J Cancer 2006; 42: 2738-2743.
-
(2006)
Eur J Cancer
, vol.42
, pp. 2738-2743
-
-
Pfeiffer, P.1
Mortensen, J.P.2
Bjerregaard, B.3
-
22
-
-
48749096430
-
QoL and resource use analysis of tegafururacil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study
-
Abstr 3631
-
Sizer B, Makris A, Barone C et al. QoL and resource use analysis of tegafururacil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. J Clin Oncol 2006; 24 (Suppl): (Abstr 3631).
-
(2006)
J Clin Oncol
, vol.24
, Issue.SUPPL.
-
-
Sizer, B.1
Makris, A.2
Barone, C.3
-
23
-
-
0034667864
-
Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer
-
Hoff PM, Janjan N, Saad ED et al. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 2000; 18: 3529-3534.
-
(2000)
J Clin Oncol
, vol.18
, pp. 3529-3534
-
-
Hoff, P.M.1
Janjan, N.2
Saad, E.D.3
-
24
-
-
5044220053
-
A phase I study of oral UFT given concomitantly with standard preoperabve radiotherapy for rectal cancer
-
Pfeffer MR, Kundel Y, Zehavi M et al. A phase I study of oral UFT given concomitantly with standard preoperabve radiotherapy for rectal cancer. Isr Med Assoc J 2004; 6: 595-598.
-
(2004)
Isr Med Assoc J
, vol.6
, pp. 595-598
-
-
Pfeffer, M.R.1
Kundel, Y.2
Zehavi, M.3
-
25
-
-
20044396718
-
Pre-operabve chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer
-
Wang LW, Yang SH, Lin JK et al. Pre-operabve chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol 2005; 89: 256-263.
-
(2005)
J Surg Oncol
, vol.89
, pp. 256-263
-
-
Wang, L.W.1
Yang, S.H.2
Lin, J.K.3
-
26
-
-
67649614659
-
Preoperatve radiaton and daily oral UFT in combinabon with leucovorin in locally advanced rectal (LARC) cancer
-
Abstr 3676
-
Gamelin E, Cellier P, Leduc B et al. Preoperatve radiaton and daily oral UFT in combinabon with leucovorin in locally advanced rectal (LARC) cancer. J Clin Oncol 2004; 22 (14 Suppl): (Abstr 3676).
-
(2004)
J Clin Oncol
, vol.22
, Issue.14 SUPPL.
-
-
Gamelin, E.1
Cellier, P.2
Leduc, B.3
-
27
-
-
4143132330
-
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up
-
Fernandez-Martos C, Aparicio J, Bosch C et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up. J Clin Oncol 2004; 22: 3016-3022.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3016-3022
-
-
Fernandez-Martos, C.1
Aparicio, J.2
Bosch, C.3
-
28
-
-
0035985283
-
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy
-
Feliu J, Calvilio J, Escribano A et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 2002; 13: 730-736.
-
(2002)
Ann Oncol
, vol.13
, pp. 730-736
-
-
Feliu, J.1
Calvilio, J.2
Escribano, A.3
-
29
-
-
0029563823
-
Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study
-
Gonzalez-Baron M, Feliu J, de la Gandara I et al. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study. Eur J Cancer 1995; 31A: 2215-2219.
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 2215-2219
-
-
Gonzalez-Baron, M.1
Feliu, J.2
de la Gandara, I.3
-
30
-
-
34547764967
-
A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer
-
Kundel Y, Brenner B, Symon Z et al. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer. Anticancer Res 2007; 27: 2877-2880.
-
(2007)
Anticancer Res
, vol.27
, pp. 2877-2880
-
-
Kundel, Y.1
Brenner, B.2
Symon, Z.3
-
31
-
-
37049017365
-
Preoperative chemoradiotherapy for rectal cancer: Randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin
-
de la Torre A, García-Berrocal MI, Arias F et al. Preoperative chemoradiotherapy for rectal cancer: Randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. Int J Radiat Oncol Biol Phys 2008; 70: 102-110.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.70
, pp. 102-110
-
-
de la Torre, A.1
García-Berrocal, M.I.2
Arias, F.3
-
32
-
-
0037086328
-
Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule
-
Cividalli A, Ceciarelli F, Livdi E et al. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule. Int J Radiat Oncol Biol Phys 2002; 52: 1092-1098.
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 1092-1098
-
-
Cividalli, A.1
Ceciarelli, F.2
Livdi, E.3
-
33
-
-
21344435197
-
A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC)
-
Abstr 3637
-
Aschele C, Vitali ML, Binda GA. A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC). J Clin Oncol 2004; 22 (14 Suppl): (Abstr 3637).
-
(2004)
J Clin Oncol
, vol.22
, Issue.14 SUPPL.
-
-
Aschele, C.1
Vitali, M.L.2
Binda, G.A.3
-
34
-
-
48749091738
-
Oxaliplatn, uracil/ tegafur (UFT) and radiotherapy in operable rectal cancer. Preliminary results of a multicenter phase II study
-
Abstr 3648
-
Fernandez-Martos C, Bosch C, Aparicio J et al. Oxaliplatn, uracil/ tegafur (UFT) and radiotherapy in operable rectal cancer. Preliminary results of a multicenter phase II study. J Clin Oncol 2005; 23 (16 Suppl): (Abstr 3648).
-
(2005)
J Clin Oncol
, vol.23
, Issue.16 SUPPL.
-
-
Fernandez-Martos, C.1
Bosch, C.2
Aparicio, J.3
-
35
-
-
48749088052
-
Preoperatve radiation with uracil/tegafur (UFT) and mitomycin C (MMC) in locally advanced rectal cancer
-
Abstr 13512
-
Gemici C, Mayadagli A, Salepci T et al. Preoperatve radiation with uracil/tegafur (UFT) and mitomycin C (MMC) in locally advanced rectal cancer. J Clin Oncol 2006; 24 (18 Suppl): (Abstr 13512).
-
(2006)
J Clin Oncol
, vol.24
, Issue.18 SUPPL.
-
-
Gemici, C.1
Mayadagli, A.2
Salepci, T.3
-
36
-
-
33845430414
-
Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
-
Yasui M, Ikeda M, Sekimoto M et al. Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer, World J Surg Oncol 2006; 4: 83.
-
(2006)
World J Surg Oncol
, vol.4
, pp. 83
-
-
Yasui, M.1
Ikeda, M.2
Sekimoto, M.3
-
37
-
-
0032986274
-
Indicatons for and results of combined modality treatment of colorectal cancer
-
Gunderson LL. Indicatons for and results of combined modality treatment of colorectal cancer. Acta Oncol 1999; 38: 7-21.
-
(1999)
Acta Oncol
, vol.38
, pp. 7-21
-
-
Gunderson, L.L.1
-
38
-
-
0028692706
-
Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer
-
Sanchiz F, Milla A. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer. Jpn J Clin Oncol 1994; 24: 322-326.
-
(1994)
Jpn J Clin Oncol
, vol.24
, pp. 322-326
-
-
Sanchiz, F.1
Milla, A.2
-
39
-
-
12244271447
-
Phase I study of oral uracil and tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer
-
Schiebe ME, Reese T, Wenz F et al. Phase I study of oral uracil and tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer. Anticancer Drugs 2002; 13: 1005-1009.
-
(2002)
Anticancer Drugs
, vol.13
, pp. 1005-1009
-
-
Schiebe, M.E.1
Reese, T.2
Wenz, F.3
-
40
-
-
21344446775
-
High-dose radiotherapy and concurrent UFT plus I-leucovorin in locally advanced rectal cancer: A phase I trial
-
Pfeiffer P. High-dose radiotherapy and concurrent UFT plus I-leucovorin in locally advanced rectal cancer: A phase I trial. Acta Oncol 2005; 44: 224-229.
-
(2005)
Acta Oncol
, vol.44
, pp. 224-229
-
-
Pfeiffer, P.1
-
41
-
-
48749113857
-
A phase II trial of high-dose radiotherapy (60 Gy) and UFT/LV in patents with advanced rectal cancer (LARC): Long-term results
-
Abstr 3590
-
Ovortrup C, Jakobsen A, Hansen F et al. A phase II trial of high-dose radiotherapy (60 Gy) and UFT/LV in patents with advanced rectal cancer (LARC): Long-term results. J Clin Oncol 2004; 22 (14 Suppl): (Abstr 3590).
-
(2004)
J Clin Oncol
, vol.22
, Issue.14 SUPPL.
-
-
Ovortrup, C.1
Jakobsen, A.2
Hansen, F.3
-
42
-
-
0032850210
-
Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer
-
de la Torre A, Ramos S, Valcarcel FJ et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1999; 45: 629-634.
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.45
, pp. 629-634
-
-
de la Torre, A.1
Ramos, S.2
Valcarcel, F.J.3
-
43
-
-
20044390067
-
Practice parameters for the management of rectal cancer (revised)
-
Tjandra JJ, Kilkenny JW, Buie WD et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48: 411-423.
-
(2005)
Dis Colon Rectum
, vol.48
, pp. 411-423
-
-
Tjandra, J.J.1
Kilkenny, J.W.2
Buie, W.D.3
-
44
-
-
0021792174
-
Prolongation at the disease-free survival in surgically treated rectal cancer
-
Gastrointestinal Tumor Study Group
-
Gastrointestinal Tumor Study Group. Prolongation at the disease-free survival in surgically treated rectal cancer. N Engl J Med 1985; 312: 1465-1472.
-
(1985)
N Engl J Med
, vol.312
, pp. 1465-1472
-
-
-
45
-
-
0026071185
-
Effective surgical adjuvant therapy for high-risk rectal carcinoma
-
Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-715.
-
(1991)
N Engl J Med
, vol.324
, pp. 709-715
-
-
Krook, J.E.1
Moertel, C.G.2
Gunderson, L.L.3
-
46
-
-
0030805013
-
Randomized control trial of postoperative radiotherapy and short-term scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer, Norwegian Adjuvant Rectal Cancer Group
-
Tveit KM, Guldvog I, Hagen S. Randomized control trial of postoperative radiotherapy and short-term scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer, Norwegian Adjuvant Rectal Cancer Group. Br J Surg 1997; 84: 1130-1135.
-
(1997)
Br J Surg
, vol.84
, pp. 1130-1135
-
-
Tveit, K.M.1
Guldvog, I.2
Hagen, S.3
-
47
-
-
0035922657
-
Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials
-
Colorectal Cancer Collaborative Group
-
Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001; 358: 1291-1304.
-
(2001)
Lancet
, vol.358
, pp. 1291-1304
-
-
-
48
-
-
33745698661
-
Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision wfth selective lateral pelvic lymphadenectomy: A multicenter randomized controlled trial
-
Akasu T, Moriya Y, Ohashi Y et al. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision wfth selective lateral pelvic lymphadenectomy: A multicenter randomized controlled trial. Jpn J Clin Oncol 2006; 36: 237-244.
-
(2006)
Jpn J Clin Oncol
, vol.36
, pp. 237-244
-
-
Akasu, T.1
Moriya, Y.2
Ohashi, Y.3
-
49
-
-
0030833057
-
Postoperative adjuvant chemotherapy with miltomycin C and UFT for rectal cancer
-
Kodaira S. Postoperative adjuvant chemotherapy with miltomycin C and UFT for rectal cancer. Oncology (Huntingt) 1997; 11 (9 Suppl 10): 40-43.
-
(1997)
Oncology (Huntingt)
, vol.11
, Issue.9 SUPPL. 10
, pp. 40-43
-
-
Kodaira, S.1
-
50
-
-
34247182068
-
An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer
-
Sakamoto J, Hamada C, Yoshida S et al. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer 2007; 96: 1170-1177.
-
(2007)
Br J Cancer
, vol.96
, pp. 1170-1177
-
-
Sakamoto, J.1
Hamada, C.2
Yoshida, S.3
-
51
-
-
0037348549
-
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
-
Millward MJ, Boyer MJ, Lehnert M et al. Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients, Ann Oncol 2003; 14: 449-454.
-
(2003)
Ann Oncol
, vol.14
, pp. 449-454
-
-
Millward, M.J.1
Boyer, M.J.2
Lehnert, M.3
-
52
-
-
4444243813
-
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV
-
Shirao K, Hoff PM, Ohtsu A et al. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV. J Clin Oncol 2004; 22: 3466-3474.
-
(2004)
J Clin Oncol
, vol.22
, pp. 3466-3474
-
-
Shirao, K.1
Hoff, P.M.2
Ohtsu, A.3
-
53
-
-
33750716502
-
Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer
-
Hsieh CH, Chen YJ, Chang KH et al. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer. Anticancer Res 2006; 26: 3709-3715.
-
(2006)
Anticancer Res
, vol.26
, pp. 3709-3715
-
-
Hsieh, C.H.1
Chen, Y.J.2
Chang, K.H.3
-
54
-
-
34447131751
-
Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer
-
Atasoy BM, Abacioglu U, Ozgen Z et al. Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. J BUON 2007; 12: 203-208.
-
(2007)
J BUON
, vol.12
, pp. 203-208
-
-
Atasoy, B.M.1
Abacioglu, U.2
Ozgen, Z.3
-
55
-
-
33644664586
-
The integraton of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: How successful have we been?
-
Glynne-Jones R, Dunst J, Sebag-Montefiore D. The integraton of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: How successful have we been? Ann Oncol 2006; 17: 361-371.
-
(2006)
Ann Oncol
, vol.17
, pp. 361-371
-
-
Glynne-Jones, R.1
Dunst, J.2
Sebag-Montefiore, D.3
-
56
-
-
0344109583
-
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
-
Meta-analysis Group In Cancer
-
Meta-analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J mClin Oncol 1998; 16: 301-308.
-
(1998)
J mClin Oncol
, vol.16
, pp. 301-308
-
-
-
57
-
-
37349040121
-
Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
-
Saif MW, Hashmi S, Zelterman D et al. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis 2008; 23: 139-145.
-
(2008)
Int J Colorectal Dis
, vol.23
, pp. 139-145
-
-
Saif, M.W.1
Hashmi, S.2
Zelterman, D.3
-
58
-
-
48749131886
-
-
UFT Summary of Product Characteristics. http://emc.medicines.org.uk/emc/ assets/c/html/DisplayDoc.asp?DocurrientD=4399 (2 August 2007, date last accessed).
-
UFT Summary of Product Characteristics. http://emc.medicines.org.uk/emc/ assets/c/html/DisplayDoc.asp?DocurrientD=4399 (2 August 2007, date last accessed).
-
-
-
-
59
-
-
40749087276
-
Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
-
Yen-Revollo JL, Goldberg RM, McLeod HL. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines? Clin Cancer Res 2008; 14: 8-13.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 8-13
-
-
Yen-Revollo, J.L.1
Goldberg, R.M.2
McLeod, H.L.3
-
60
-
-
33144459846
-
Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer
-
Kim JS, Kim JS, Cho MJ et al. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. J Korean Med Sci 2006; 21: 52-57.
-
(2006)
J Korean Med Sci
, vol.21
, pp. 52-57
-
-
Kim, J.S.1
Kim, J.S.2
Cho, M.J.3
-
61
-
-
33846229229
-
Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer
-
Kim DY, Jung KH et al. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer: Int J Radiat Oncol Biol Phys 2007; 67: 378-384.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 378-384
-
-
Kim, D.Y.1
Jung, K.H.2
-
62
-
-
33751179691
-
Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis
-
Das P, Lin EH, Bhatia S et al. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis, Int J Radiat Oncol Biol Phys 2006; 66: 1378-1383.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 1378-1383
-
-
Das, P.1
Lin, E.H.2
Bhatia, S.3
-
63
-
-
0034162884
-
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
-
Wolmark N, Wieand HS, Hyams DM et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92: 388-396.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 388-396
-
-
Wolmark, N.1
Wieand, H.S.2
Hyams, D.M.3
|